1 new LinkedIn ad in 30 days · 2 of 3 networks checked
Manus ads
- manusbio.com
- Biotechnology Research
- US
- 188 employees
Manus’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to browse our full recording. Watch Manus on any plan to get each new one in your feed.
Watchlist included in every plan
What Manus runs
- Single image · LinkedIn
- 6
| Network | Status | Last 30 days | Total ads found | Ad activity | Checked | Next step |
|---|---|---|---|---|---|---|
| Ads recorded | 1 | 43+ | 11/10/2026 | View ads → | ||
| Meta | Not checked | — | — | View ads → | ||
| None recorded | — | — | 11/03/2026 | View ads → |
Manus has 1 new LinkedIn ad in the last 30 days. We recorded no Google ads on 3 Nov 2026.
Latest ads
- LINKEDIN · IMAGESince 24 Aug 2026
With the advent of new European regulations surrounding new genomic techniques, there has never been a better time to help your vision take root. With MAD7®, developed by Inscripta and backed by Manus, scale your projects as desired using a powerful, flexible, and cost-effective CRISPR tool designed for precise genome-editing. Discover MAD7® today.
- LINKEDIN · IMAGESince 24 Aug 2026
With recent changes to European regulations around gene-edited crops, the opportunity to innovate is stronger than ever. Which is where we come in. With the MAD7® Licensing Program, developed by Inscripta and backed by Manus, we offer expanded access to a best-in-class CRISPR tool designed to take your R&D further than ever before. Giving you the power and flexibility to turn breakthrough biotechnology into real-world impact.
- LINKEDIN · IMAGESince 20 Jan 2026
Ready for something MAD? Meet MAD7 – a powerful, flexible, and cost-effective tool for precise genome editing, designed to accelerate your R&D. Backed by Manus, the MAD7 licensing program is an independent and trusted resource for researchers and partners worldwide – part of our broader purpose as The BioAlternatives Company to turn breakthrough biotechnology into real-world impact.
- LINKEDIN · IMAGESince 20 Jan 2026
Ready for something MAD? Meet MAD7® – a powerful, flexible, and cost-effective tool for precise genome editing, designed to accelerate your R&D. Explore MAD7 – and unlock your next discovery: https://lnkd.in/d9CQPC_d Backed by Manus, the MAD7 licensing program is an independent and trusted resource for researchers and partners worldwide – part of our broader purpose as The BioAlternatives Company to turn breakthrough biotechnology into real-world impact.
- LINKEDIN · IMAGESince 20 Jan 2026
Ready for something MAD? Meet MAD7® – a powerful, flexible, and cost-effective tool for precise genome editing, designed to accelerate your R&D. Explore MAD7 – and unlock your next discovery: https://lnkd.in/dGiv9hrv Backed by Manus, the MAD7 licensing program is an independent and trusted resource for researchers and partners worldwide – part of our broader purpose as The BioAlternatives Company to turn breakthrough biotechnology into real-world impact.
- LINKEDIN · IMAGESince 20 Jan 2026
At Manus, we believe genome editing should be accessible, scalable, and ready for real-world impact. MAD7® helps make that possible.
6 of 43+ adsSign up to see every Manus ad, filter by format and date, and get alerts on new ones.
See all 43+ adsQuestions about Manus’s ads
Does Manus have new LinkedIn ads?
Yes. We found 1 new LinkedIn ad for Manus in the 30 days to 12 Nov 2026.
How many LinkedIn ads has Manus run?
LinkedIn’s ad library lists 43 ads for Manus. We recorded 43 LinkedIn ads for Manus, first recorded on 25 Sept 2026 and last recorded on 17 Oct 2026.
Does Manus run Google ads?
We recorded no Google ads for the domain manusbio.com on 3 Nov 2026.
Which ad formats does Manus use?
The 6 LinkedIn ads on this page include 6 image ads.
Watch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.